about
Cell based therapies for ischemic stroke: from basic science to bedsideNeuroinflammation and cerebrovascular disease in old age: a translational medicine perspectiveArgon: systematic review on neuro- and organoprotective properties of an "inert" gas.Therapeutic time window and dose dependence of xenon delivered via echogenic liposomes for neuroprotection in stroke.Protective efficacy of a single salvianolic acid A treatment on photothrombosis-induced sustained spatial memory impairmentsNeural stem cell protects aged rat brain from ischemia-reperfusion injury through neurogenesis and angiogenesis.Protective effects of incensole acetate on cerebral ischemic injury.An L-type calcium channel agonist, bay K8644, extends the window of intervention against ischemic neuronal injury.Emerging Therapies: Pleiotropic Multi-target Drugs to Treat Stroke VictimsDefining the ischemic penumbra using hyperacute neuroimaging: deriving quantitative ischemic thresholdsUnraveling the ischemic brain transcriptome in a permanent middle cerebral artery occlusion mouse model by DNA microarray analysis.A novel snake venom-derived GPIb antagonist, anfibatide, protects mice from acute experimental ischaemic stroke and reperfusion injury.Erythropoietin: still on the neuroprotection roadAutophagy biomarkers in CSF correlates with infarct size, clinical severity and neurological outcome in AIS patients.Cellular mechanisms of neurovascular damage and repair after strokeNeuroprotective Effects of Isosteviol Sodium Injection on Acute Focal Cerebral Ischemia in RatsDrug-like property profiling of novel neuroprotective compounds to treat acute ischemic stroke: guidelines to develop pleiotropic moleculesSafety and efficacy evaluation of carnosine, an endogenous neuroprotective agent for ischemic stroke.Lettuce glycoside B ameliorates cerebral ischemia reperfusion injury by increasing nerve growth factor and neurotrophin-3 expression of cerebral cortex in rats.Phase I and Phase II Therapies for Acute Ischemic Stroke: An Update on Currently Studied Drugs in Clinical Research.Selective 14-3-3γ induction quenches p-β-catenin Ser37/Bax-enhanced cell death in cerebral cortical neurons during ischemia.Lyophilized Powder of Catalpol and Puerarin Protected Cerebral Vessels from Ischemia by Its Anti-apoptosis on Endothelial Cells.Compound porcine cerebroside and ganglioside injection attenuates cerebral ischemia-reperfusion injury in rats by targeting multiple cellular processesTRPM7 in cerebral ischemia and potential target for drug development in stroke.Gene transfer mediated by stem cell grafts to treat CNS injury.Therapeutic potential of targeting hydrogen peroxide metabolism in the treatment of brain ischaemia.Neuroprotection for ischaemic stroke: translation from the bench to the bedside.Challenges in acute ischemic stroke clinical trials.Neuroprotection against hypoxia/ischemia: δ-opioid receptor-mediated cellular/molecular events.Ginsenoside Rd for acute ischemic stroke: translating from bench to bedside.New strategies in the management of Guillain-Barré syndrome.Acute resveratrol treatment modulates multiple signaling pathways in the ischemic brain.Caveolae: molecular insights and therapeutic targets for stroke.Prehospital stroke care: telemedicine, thrombolysis and neuroprotection.Amelioration of stroke-induced neurological deficiency by lyophilized powder of catapol and puerarin14-3-3 Isoforms Differentially Regulate NFκB Signaling in the Brain After Ischemia-Reperfusion.MIT-Skywalker: considerations on the Design of a Body Weight Support System.MIT-Skywalker: A Novel Gait Neurorehabilitation Robot for Stroke and Cerebral Palsy.Modulation of mitochondrial function and autophagy mediates carnosine neuroprotection against ischemic brain damage.Loss of Integrity: Impairment of the Blood-brain Barrier in Heavy Metal-associated Ischemic Stroke.
P2860
Q27025754-40632857-6365-4AA3-B108-C51FB6464EDCQ28393202-BFCD0087-EB53-48C6-BB87-9E54B0A22485Q30426331-9C8AD3AF-9939-49C2-9174-C446A7736901Q30429580-AFAAB377-2F2D-4B53-9589-1FB9FD9B5669Q33631320-B877B25F-DFC4-4812-9FBD-DD8EA853D894Q33851455-B061AC89-786B-4B91-B3CE-C32758321E00Q34250174-B860EED1-A212-4FEC-947F-FAC607C4F43FQ34440328-2F1BC46F-E793-4531-A8FF-49BA5EECAB9BQ35029799-1C098CDB-7E55-4915-A807-00D08BE498B8Q35624277-965F39D3-5EC1-4FDC-B298-7B3E5F8F0039Q35794591-E28547B8-833F-4960-9200-FF3AD9247EC2Q35911764-E70157A8-2FCB-4EAC-9DF6-AE9795DCD90CQ35949322-4442580C-1DD8-46C4-B696-78BC9DF8D66DQ36294163-AF597042-5E2C-4FF4-B2DB-AFC19557921FQ36488682-6EC520AB-FF61-4EB7-A7CA-3B59D37D407EQ36707284-44E7F54E-158B-473F-8A9A-A4D52420F0E0Q36841904-4F6C335D-E012-4FF3-BD50-7A478FC7057DQ36917400-1D02B9D3-D15A-4832-B0B0-61440E370E21Q37551521-E60C77BA-47C7-4495-8CBB-E1D64C27CB2EQ37670794-EEF782C4-3331-4FFB-B78D-09211FC7B4E8Q37726133-59C7188E-462A-4E62-9143-5815FDE015D7Q37726230-60992CF3-69E5-4FD2-BA0B-3C93AD824EECQ37733195-20C351EF-DF6C-4E9E-AF3A-8B1B208C2B34Q37873298-434920B0-CE5E-422B-B8E5-23D9A6B22433Q37948144-DF71436D-6FF6-43F1-9DF9-F03178498F62Q37986853-7CE1E931-A235-488E-89B5-B55E4CE4A1E5Q37991061-EC82BD5C-674B-481A-923A-4D84BDDAD77BQ38038048-15CB0D5B-B49C-45D1-8917-650F6875C1E7Q38046756-B47226FA-A371-45C6-8045-A936F8980E7EQ38112210-13CC6E1E-F71C-49BF-B866-4D2A779BD450Q38140727-C0E74316-1E2B-4271-B4F4-277DF9ADB2D1Q38322823-271087CA-AF7B-4C97-A071-4B1A0A6E782DQ38339343-0F5CE295-4D0E-4DB7-ABBA-E25AF102D38FQ38537388-566AEE46-2C39-495D-928A-1B7679C10BACQ38664720-6234C6B1-1FD7-47DD-B9FD-949651219B79Q38829472-29924BE1-8BCF-423A-A693-131D26C95901Q41590481-E89C8388-DF22-400A-BA15-F0B6BE4AF933Q41643708-F17615BF-FA0B-4EAB-AB0B-6075FBF8406CQ41827290-0AE7C573-B66E-4EFF-AAEC-42F6607A770EQ41845503-174A4175-5ABA-45C7-9A68-133D898BC96F
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
New approaches to neuroprotective drug development.
@ast
New approaches to neuroprotective drug development.
@en
New approaches to neuroprotective drug development.
@nl
type
label
New approaches to neuroprotective drug development.
@ast
New approaches to neuroprotective drug development.
@en
New approaches to neuroprotective drug development.
@nl
prefLabel
New approaches to neuroprotective drug development.
@ast
New approaches to neuroprotective drug development.
@en
New approaches to neuroprotective drug development.
@nl
P1433
P1476
New approaches to neuroprotective drug development.
@en
P2093
Marc Fisher
P356
10.1161/STROKEAHA.110.592394
P407
P433
P577
2010-12-16T00:00:00Z